Study
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001004953 | Other |
Study Description
WES and clonality characterization of different timepoints in HER2-negative primary breast cancers receiving neoadjuvant eribulin therapy.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001006980 |
Temporal HER2-negative breast cancers WES
|
Illumina HiSeq 2500 | 94 |
Who archives the data?
